Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.310
-0.010 (-0.76%)
At close: Feb 27, 2026, 4:00 PM EST
1.310
0.00 (-0.01%)
After-hours: Feb 27, 2026, 7:52 PM EST
Akebia Therapeutics Employees
Akebia Therapeutics had 181 employees as of December 31, 2024. The number of employees increased by 14 or 8.38% compared to the previous year.
Employees
181
Change (1Y)
14
Growth (1Y)
8.38%
Revenue / Employee
$1,304,950
Profits / Employee
-$29,530
Market Cap
350.92M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aurora Cannabis | 1,073 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 420 |
| Lifecore Biomedical | 406 |
| Evolus | 329 |
| Aquestive Therapeutics | 142 |
AKBA News
- 2 days ago - Akebia Therapeutics, Inc. (AKBA) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Akebia Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Commercial and Pipeline Highlights - GlobeNewsWire
- 9 days ago - Akebia Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Discuss Recent Business Highlights - GlobeNewsWire
- 15 days ago - Akebia Therapeutics, Inc. (AKBA) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript - Seeking Alpha
- 24 days ago - Akebia Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 26 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 6 weeks ago - Akebia Post-Selloff: Revenue Dynamics And Upcoming Catalysts - Seeking Alpha
- 6 weeks ago - Akebia Therapeutics Announces Corporate Updates and 2026 Pipeline Outlook - GlobeNewsWire